AU654607B2 - New pyridylsulphonylurea compound, processes for the preparation thereof, and pharmaceutical compositions containing it - Google Patents

New pyridylsulphonylurea compound, processes for the preparation thereof, and pharmaceutical compositions containing it Download PDF

Info

Publication number
AU654607B2
AU654607B2 AU31015/93A AU3101593A AU654607B2 AU 654607 B2 AU654607 B2 AU 654607B2 AU 31015/93 A AU31015/93 A AU 31015/93A AU 3101593 A AU3101593 A AU 3101593A AU 654607 B2 AU654607 B2 AU 654607B2
Authority
AU
Australia
Prior art keywords
compound
ischaemia
prevention
treatment
pyrid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU31015/93A
Other languages
English (en)
Other versions
AU3101593A (en
Inventor
Jacques Delarge
Bernard Masereel
Bernard Pirotte
Marc Schynts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADIR SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Publication of AU3101593A publication Critical patent/AU3101593A/en
Application granted granted Critical
Publication of AU654607B2 publication Critical patent/AU654607B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
AU31015/93A 1992-01-06 1993-01-05 New pyridylsulphonylurea compound, processes for the preparation thereof, and pharmaceutical compositions containing it Ceased AU654607B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9200031A FR2685917A1 (fr) 1992-01-06 1992-01-06 Nouveau derive de la pyridylsulfonyluree des procedes de preparation et les compositions pharmaceutiques le contenant.
FR9200031 1992-01-06

Publications (2)

Publication Number Publication Date
AU3101593A AU3101593A (en) 1993-07-08
AU654607B2 true AU654607B2 (en) 1994-11-10

Family

ID=9425396

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31015/93A Ceased AU654607B2 (en) 1992-01-06 1993-01-05 New pyridylsulphonylurea compound, processes for the preparation thereof, and pharmaceutical compositions containing it

Country Status (8)

Country Link
US (1) US5391559A (enExample)
EP (1) EP0551219A1 (enExample)
JP (1) JPH0684353B2 (enExample)
AU (1) AU654607B2 (enExample)
CA (1) CA2086698A1 (enExample)
FR (1) FR2685917A1 (enExample)
NZ (1) NZ245619A (enExample)
ZA (1) ZA9364B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559151A (en) * 1994-11-30 1996-09-24 Allergan Method for reducing intraocular pressure in the mammalian eye by administration of chloride channel blockers
ITMI20022749A1 (it) * 2002-12-23 2004-06-24 Cosma S P A Nuovo procedimento per la sintesi della tosemide, in particolare della forma ii pura e stabile.

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4331779A (en) * 1978-01-31 1979-08-09 Farmitalia Carlo Erba S.R.L. Derivatives of pyridine
AU7198191A (en) * 1990-03-02 1991-09-05 Adir Et Compagnie New derivatives of pyridylsulfonylurea and of pyridylsulfonylthiourea, process for preparing these and pharmaceutical compositions containing them

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4331779A (en) * 1978-01-31 1979-08-09 Farmitalia Carlo Erba S.R.L. Derivatives of pyridine
AU7198191A (en) * 1990-03-02 1991-09-05 Adir Et Compagnie New derivatives of pyridylsulfonylurea and of pyridylsulfonylthiourea, process for preparing these and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
JPH061766A (ja) 1994-01-11
JPH0684353B2 (ja) 1994-10-26
EP0551219A1 (fr) 1993-07-14
ZA9364B (en) 1993-08-03
FR2685917B1 (enExample) 1995-06-02
CA2086698A1 (fr) 1993-07-07
NZ245619A (en) 1994-10-26
AU3101593A (en) 1993-07-08
FR2685917A1 (fr) 1993-07-09
US5391559A (en) 1995-02-21

Similar Documents

Publication Publication Date Title
DE69133299T2 (de) Aminosulfonylcarbamate
DE68911203T2 (de) N-[[(2,6-disubstituierte)phenyl]N'- arylalkyl] Harnstoffe als antihypercholesterolemische und antiatherosclerotische Mittel.
US5441984A (en) Urea, thiourea and guanidine derivatives
JPH0585935A (ja) 抗ウイルス性促進方法
EP1032556B1 (en) Pharmaceutically active compounds and methods of use
US7145037B2 (en) Adamantane derivatives with neuroprotective, antidepressant and anti-ischaemic activities, and process for preparing them
EP1370525B1 (en) Biguanide derivatives
US5166162A (en) Pyridylsulfonylurea and pyridylsulfonylthiourea compounds
EP0723956A1 (de) Basisch-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
US5391559A (en) New pyridylsulphonylurea compound
EP1513834B1 (de) Substituierte thiophene, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament
EP1445250A1 (en) Novel amine derivative having human beta-tryptase inhibitory activity and drugs containing the same
EP1245561B1 (en) N-substituted benzyl or phenyl aromatic sulfamides compounds and the use thereof
NO134928B (enExample)
DE1493672A1 (de) Verfahren zur Herstellung von Benzolsulfonylharnstoffen
DE69416324T2 (de) Heterocyclische benzolsulfonyliminderivate als inhibitoren der il-1 wirkung
PL149466B1 (en) Method of obtaining novel polymorph i of mononoethanolamine n-/2-pyridilo/-2-methyl-4-hydroxy-2h-1,2-benzothiazin-3-carbonamide 1,1-dioxide salt
Masereel et al. Synthesis and pharmacology of pyrid-3-yl sulfonylureas and thioureas as astrocytic Na+ 2C1− K+ cotransporter inhibitors
DE3875820T2 (de) Aromatische heterozyklische karbonsaeureamidabkoemmlinge, verfahren zur herstellung und arzneimittel, die diese enthalten.
US6518458B1 (en) (Aminoiminomethyl) amino) alkane-carboxamides and their applications in therapy
AU2003221636B2 (en) Amino acid analogues
AU632399B2 (en) New derivatives of pyridylsulfonylurea and of pyridylsulfonylthiourea, process for preparing these and pharmaceutical compositions containing them
Hynes et al. Synthesis and evaluation of 6-arylacetamido-2, 4-diaminoquinazolines and related compounds as folic acid antagonists
US6284795B1 (en) Sulfonamide compounds and methods of treating atherosclerosis and restenosis
US20080146621A1 (en) Polysubstituted 1,1-pyridylaminocyclopropanamine compounds